Publications by authors named "Gary Shanguan"

Claim this Profile
A
A novel C-terminal Hsp90 inhibitor KU758 synergizes efficacy in combination with BRAF or MEK inhibitors and targets drug-resistant pathways in BRAF-mutant melanomas.
Jackee N Sanchez, Chitra Subramanian, Monica Chanda, Gary Shanguan, Nina Zhang

Melanoma Resยท June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis